Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06058559 · ClinicalTrials.gov registry record · NA

Effect of Sunflower Lecithin Supplementation on Meibomian Gland Function in Adults With Dry Eye Disease

A NA study, sponsored by George Washington University.

Completed
Registry status
NA
Development phase
31
Enrollment target

NCT06058559: Completed NA study, sponsored by George Washington University.

NCT06058559 is a NA study that has completed, run by George Washington University. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06058559, a NA study, has completed, sponsored by George Washington University.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target

Study Summary

This prospective study will evaluate the effect of oral sunflower lecithin dietary supplementation on meibomian gland function in adults with dry eye disease.

Primary Outcome

To assess the improvement of dry eye symptoms by SPEED questionnaire. 0 score is the minimum (no dry eye symptom); 64 is the maximum score (most symptomatic). Change = (Day 90 score - Baseline score)

Interventions

  • DIETARY_SUPPLEMENT Olive oil
  • DIETARY_SUPPLEMENT Sunflower lecithin

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2023-06-20
Est. Completion 2023-10-26
Phase NA
George Washington University

133 total trials

What the finished NCT06058559 record still lists

NCT06058559 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Olive oil is the first listed.

NCT06058559 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06058559 about?

NCT06058559 is a clinical study titled "Effect of Sunflower Lecithin Supplementation on Meibomian Gland Function in Adults With Dry Eye Disease". This prospective study will evaluate the effect of oral sunflower lecithin dietary supplementation on meibomian gland function in adults with dry eye disease.

What is the current status of trial NCT06058559?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2023-06-20. Estimated completion is 2023-10-26.

What interventions are being tested in trial NCT06058559?

The interventions under investigation include: Olive oil (DIETARY_SUPPLEMENT), Sunflower lecithin (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06058559?

This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06058559's enrollment target sits among peer trials

31 1592nd of 2000 higher than 408 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06058559, the US trial registry maintained by the National Library of Medicine. NCT06058559 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.